
Baxter Launches Zosyn Premix In US
Apr 4, 2023 · Zosyn premix is indicated for the treatment of multiple infections caused by susceptible bacteria and is available in Baxter’s proprietary single-dose Galaxy containers. …
With Zosyn (piperacillin and tazobactam) Injection
Baxter is the only manufacturer of premix piperacillin and tazobactam injection. Using Zosyn premix eliminates the need for reconstitution, saving nearly 5 minutes for each 3.375 g/50 mL …
ZOSYN (piperacillin and tazobactam injection) is available with …
Baxter offers practical and innovative products in premix ready-to-use IV formulations, including frozen, which may increase hospital efficiency while helping to support patient care. How might …
Pharmaceuticals at Baxter Ready-to-Use Premix Medications
Baxter offers practical and innovative medications in premixed ready-to-use IV formulations, which may help increase hospital efficiency, and support patient safety protocols. 1,2 Learn about …
sterile medication production and delivery, today announced the U.S. launch of ZOSYN (piperacillin and tazobactam) Injection. Zosyn premix is indicated for the treatment of multiple …
Piperacillin 10 mg/mL plus tazobactam 1.25 mg/mL (Lederle) in dextrose 5% was found to be compatible with the ARROW-g+ard Blue Plus (Arrow International) chlorhexidine-bearing triple …
The first and only premix piperacillin and tazobactam injection is manufactured by and available from Baxter — the leader in frozen premix IV anti-infectives. Barcoded for bedside scanning to …
Product Catalog - Baxter
Jan 9, 2025 · ZOSYN (Piperacillin and Tazobactam Injection) in GALAXY Container, 4.5g in 100mL, Single-Dose Plastic Container, Frozen Premix
Ready-to-Use Formulation of Zosyn Injection Now Available
Apr 4, 2023 · Baxter has announced the launch of a frozen premix formulation of Zosyn (piperacillin and tazobactam) Injection. The ready-to-use formulation consists of piperacillin, a …
ated in adults for the treatment of uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses and ischemic/diabetic foot inf.